BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22702364)

  • 1. DNA methylation biomarkers in cancer: progress towards clinical implementation.
    Mikeska T; Bock C; Do H; Dobrovic A
    Expert Rev Mol Diagn; 2012 Jun; 12(5):473-87. PubMed ID: 22702364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients.
    Dietrich D; Hasinger O; Liebenberg V; Field JK; Kristiansen G; Soltermann A
    Diagn Mol Pathol; 2012 Jun; 21(2):93-104. PubMed ID: 22555092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
    J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of DNA methylation for cancer detection: promises and challenges.
    Zhu J; Yao X
    Int J Biochem Cell Biol; 2009 Jan; 41(1):147-54. PubMed ID: 18834953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylated genes as new cancer biomarkers.
    Duffy MJ; Napieralski R; Martens JW; Span PN; Spyratos F; Sweep FC; Brunner N; Foekens JA; Schmitt M;
    Eur J Cancer; 2009 Feb; 45(3):335-46. PubMed ID: 19138839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivating the expression of methylation silenced genes in human cancer.
    Karpf AR; Jones DA
    Oncogene; 2002 Aug; 21(35):5496-503. PubMed ID: 12154410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic biomarkers in lung cancer.
    Liloglou T; Bediaga NG; Brown BR; Field JK; Davies MP
    Cancer Lett; 2014 Jan; 342(2):200-12. PubMed ID: 22546286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DNA methylation: potential for diagnosis, prognosis and therapy--prediction in oncology].
    Haedicke W; Lesche R
    Verh Dtsch Ges Pathol; 2006; 90():39-45. PubMed ID: 17867578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation in cancer: a gene silencing mechanism and the clinical potential of its biomarkers.
    Fukushige S; Horii A
    Tohoku J Exp Med; 2013 Mar; 229(3):173-85. PubMed ID: 23419314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of promoter CpG island hypermethylation in cancer: location, location, location!
    van Vlodrop IJ; Niessen HE; Derks S; Baldewijns MM; van Criekinge W; Herman JG; van Engeland M
    Clin Cancer Res; 2011 Jul; 17(13):4225-31. PubMed ID: 21558408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers.
    Deng D; Liu Z; Du Y
    Adv Genet; 2010; 71():125-76. PubMed ID: 20933128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
    Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
    Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic DNA methylation.
    Samlowski WE; Leachman SA; Wade M; Cassidy P; Porter-Gill P; Busby L; Wheeler R; Boucher K; Fitzpatrick F; Jones DA; Karpf AR
    J Clin Oncol; 2005 Jun; 23(17):3897-905. PubMed ID: 15753459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging roles of DNA methylation in the clinical management of prostate cancer.
    Perry AS; Foley R; Woodson K; Lawler M
    Endocr Relat Cancer; 2006 Jun; 13(2):357-77. PubMed ID: 16728568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic markers of early tumor development.
    Dumitrescu RG
    Methods Mol Biol; 2012; 863():3-14. PubMed ID: 22359284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation biomarkers of cancer: moving toward clinical application.
    Levenson VV
    Pharmacogenomics; 2004 Sep; 5(6):699-707. PubMed ID: 15335290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk stratification in medulloblastoma: screening for molecular markers].
    Ebinger M; Senf L; Scheurlen W
    Klin Padiatr; 2006; 218(3):139-42. PubMed ID: 16688669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation as a biomarker in breast cancer.
    Martens JW; Margossian AL; Schmitt M; Foekens J; Harbeck N
    Future Oncol; 2009 Oct; 5(8):1245-56. PubMed ID: 19852739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation and cancer.
    Kulis M; Esteller M
    Adv Genet; 2010; 70():27-56. PubMed ID: 20920744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylated genes as potential biomarkers in prostate cancer.
    Phé V; Cussenot O; Rouprêt M
    BJU Int; 2010 May; 105(10):1364-70. PubMed ID: 20067451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.